First Eagle Investment Management’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

First Eagle Investment Management’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-200,000	Closed	-$346K	–	352
2015 Q4	$346K	Sell	200,000 -125,559	-39%	-$221K	﹤0.01%	251
2015 Q3	$612K	Hold	325,559	–	–	﹤0.01%	238
2015 Q2	$762K	Buy	325,559 +211,103	+184%	+$651K	﹤0.01%	229
2015 Q1	$501K	Hold	114,456	–	–	﹤0.01%	249
2014 Q4	$552K	Hold	114,456	–	–	﹤0.01%	251
2014 Q3	$476K	Hold	114,456	–	–	﹤0.01%	252
2014 Q2	$674K	Sell	114,456 -38,344	-25%	-$218K	﹤0.01%	242
2014 Q1	$975K	Buy	+152,800	New	+$1.38M	﹤0.01%	210

Other funds holding TLOG

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

First Eagle Investment Management's TLOG Position: Q1 2016 in Review

First Eagle Investment Management sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q1 2016, closing a stake of 200,000 shares — an estimated $346K sold.

First Eagle Investment Management first reported a position in TLOG in Q1 2014 and held it in 8 quarters. The position peaked at $975K in Q1 2014. 25 funds tracked by Wall St. Rank hold TLOG as of Q1 2016.

First Eagle Investment Management reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q1 2016 after selling out during the quarter.
First Eagle Investment Management sold 200,000 TetraLogic Pharmaceuticals Corporation shares in Q1 2016, an estimated $346K.
First Eagle Investment Management first reported a position in TetraLogic Pharmaceuticals Corporation in Q1 2014 and held it in 8 quarters.
First Eagle Investment Management's TetraLogic Pharmaceuticals Corporation position peaked at $975K in Q1 2014.
25 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q1 2016.

Based on First Eagle Investment Management's 13F filing for Q1 2016, filed 5 May 2016.